首页> 中文期刊> 《中国药业》 >马来酸麦角新碱与缩宫素预防高危产妇产后出血效果比较

马来酸麦角新碱与缩宫素预防高危产妇产后出血效果比较

         

摘要

Objective To compare the effect of ergometrine maleate and oxytocin for the prevention of postpartum hemorrhage. Methods Totally 200 high-risk parturient women admitted to our hospital were retrospectively analyzed and divided into the observa-tion group and the control group according to the use of different drugs for preventing postpartum hemorrhage,100 cases in each group. The observation group was given oxytocin,while the control group was given ergometrine maleate. Results The total effective rate and incidence rate of adverse reaction in the observation group were 95. 00% and 4. 00%,respectively,which were obviously superior to 85. 00% and 13. 00% in the control group( P < 0. 05). The bleeding volume of the observation group after 2,24 h was significantly less than that of the control group ( P < 0. 05). Conclusion The effect of oxytocin in the prevention of postpartum hemorrhage of high-risk parturient women was significantly better than ergonovine maleate. It is safe,reliable,and can effectively reduce the bleeding volume,which is worthy of clinical promotion.%目的 比较马来酸麦角新碱与缩宫素预防高危产妇产后出血的效果.方法 回顾性分析医院收治的高危产妇200例,并根据预防产后出血药物的不同分为观察组与对照组,各100例.观察组给予缩宫素,对照组使用马来酸麦角新碱.结果 观察组的总有效率和不良反应发生率分别为95.00%和4.00%,明显优于对照组的85.00%和13.00%(P<0.05);观察组产妇术中及产后2,24 h时出血量均明显少于对照组(P<0.05).结论 缩宫素预防高危产妇产后出血的效果较马来酸麦角新碱显著,且安全、可靠,还可有效降低产妇的出血量,值得临床推广.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号